A/P 12.5/15 (Alogliptin Benzoate and Pioglitazone Hydrochloride 12.5 mg / 15 mg)
Pill with imprint A/P 12.5/15 is Yellow, Round and has been identified as Alogliptin Benzoate and Pioglitazone Hydrochloride 12.5 mg / 15 mg. It is supplied by Perrigo New York Inc..
Alogliptin/pioglitazone is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Alogliptin/pioglitazone 12.5 mg / 15 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for A/P 12.5/15
Alogliptin Benzoate and Pioglitazone Hydrochloride
- Imprint:
- A/P 12.5/15
- Strength:
- 12.5 mg / 15 mg
- Color:
- Yellow
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Perrigo New York Inc.
- National Drug Code (NDC):
- 45802-0238
More about alogliptin/pioglitazone
- Alogliptin/pioglitazone Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 1 Review
- Drug class: antidiabetic combinations
- FDA Alerts (5)
Consumer resources
Other brands: Oseni
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
